Allopurinol adjuvant in acute lymphoblastic leukaemia maintenance: Benefits and potential risks

Allopurinol adjuvant in acute lymphoblastic leukaemia maintenance: Benefits and potential risks

Saved in:

Bibliographic Details
Main Authors:	Duhita Sengupta, Manash Pratim Gogoi, Pritam Singha Roy, Shekhar Krishnan, Niharendu Ghara
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	Pediatric Hematology Oncology Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468124524003516
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effective standardisation and personalisation optimise the management of acute lymphoblastic leukaemia maintenance treatment and improve outcomes
by: Manash Pratim Gogoi, et al.
Published: (2024-01-01)

Fate of children after the first relapse of acute lymphoblastic leukemia: InPOG-ALL-19-02 study
by: Pritam Singha Roy, et al.
Published: (2024-01-01)

Comparative treatment costs of risk‐stratified therapy for childhood acute lymphoblastic leukemia in India
by: Tushar Mungle, et al.
Published: (2023-02-01)

Clinical and pharmacological monitoring of Asviia, a biogeneric polyethylene glycol-conjugated E. coli asparaginase
by: Bishwaranjan Jana, et al.
Published: (2024-01-01)

KMT2A-rearranged acute lymphoblastic leukaemia
by: Rishi S. Kotecha, et al.
Published: (2024-12-01)

Prophylactic probiotics for diarrhoea in children with acute lymphoblastic leukaemia
by: Zamil Ahmed, et al.
Published: (2024-01-01)

A shorter induction corticosteroid reduces acute lymphoblastic leukaemia induction deaths in the icicle-all-14 randomised trial
by: Parag Das, et al.
Published: (2024-01-01)

Imaging Flow Cytometric Identification of Chromosomal Defects in Paediatric Acute Lymphoblastic Leukaemia
by: Ana P. A. Simpson, et al.
Published: (2025-01-01)

A meta-analysis of the prognostic significance of CDKN deletions in acute lymphoblastic leukaemia
by: Xiaoshan Hu, et al.
Published: (2024-12-01)

Risk-stratified management of fever neutropenia in paediatric oncology patients: An audit of antimicrobial stewardship initiative in a tertiary cancer centre
by: Arpita Bhattacharyya, et al.
Published: (2024-01-01)

Prevalence of osteonecrosis in survivors of childhood acute lymphoblastic leukaemia of Indian ethnicity treated with BFM protocol
by: Sanjeev Khera, et al.
Published: (2024-01-01)

Door-to-needle time for treating fever neutropenia in children with cancer within the golden hour: A follow-up audit from a tertiary-care cancer hospital
by: Sharmin Nahar, et al.
Published: (2024-01-01)

Door-to-needle time for treating fever neutropenia in children with cancer within the golden hour: A follow-up audit from a tertiary-care cancer hospital
by: Sharmin Nahar, et al.
Published: (2024-01-01)

PAX5 fusions in precursor B cell lymphoblastic leukaemia: A single center experience
by: Parichay singh, et al.
Published: (2024-01-01)

A review of immunotargeted therapy for Philadelphia chromosome positive acute lymphoblastic leukaemia: making progress in chemotherapy-free regimens
by: Zhen-Yu Xiong, et al.
Published: (2024-12-01)

National, clinical cohort study of late effects among survivors of acute lymphoblastic leukaemia: the ALL-STAR study protocol
by: Kjeld Schmiegelow, et al.
Published: (2021-02-01)

Results from patient-derived xenograft models support co-administration of allopurinol and 6-mercaptopurine to reduce hepatotoxicity and improve event-free survival in pediatric acute lymphoblastic leukemia
by: Yixiao Mo, et al.
Published: (2025-01-01)

Vitamin E and N-Acetylcysteine as Antioxidant Adjuvant Therapy in Children with Acute Lymphoblastic Leukemia
by: Youssef Al-Tonbary, et al.
Published: (2009-01-01)

Direct and indirect costs of families with a child with acute lymphoblastic leukaemia in an academic hospital in China: a cross-sectional survey
by: Xin Li, et al.
Published: (2019-07-01)

ID1 and ID3 functions in the modulation of the tumour immune microenvironment in adult patients with B-cell acute lymphoblastic leukaemia
by: Nathaly Poveda-Garavito, et al.
Published: (2024-11-01)

What are the volume and budget needs to provide chemotherapy to all children with acute lymphoblastic leukaemia in Thailand? Development and application of an estimation tool
by: Alessandra Ferrario, et al.
Published: (2020-10-01)

Copy number alterations in Pb acute lymphoblastic leukaemia (Pb-all) and proposal for a new integrated risk stratification system
by: Ajmeera Azeez, et al.
Published: (2024-01-01)

Rituximab monotherapy in precursor-B-Cell acute Lymphoblastic leukaemia: Managing relapse or graft rejection post-allogenic bone marrow transplant
by: Rachit Khandelwal, et al.
Published: (2024-01-01)

Prevalence, clinical and hematological profile and outcome of BCR-ABL1-like acute lymphoblastic leukaemia in Indian children: A prospective observational study
by: Sanjeev Khera, et al.
Published: (2024-01-01)

Prevalence, clinical and hematological profile and outcome of BCR-ABL1-like acute lymphoblastic leukaemia in Indian children: A prospective observational study
by: Sanjeev Khera, et al.
Published: (2024-01-01)

DRESSed for distress: a case of allopurinol-induced DRESS syndrome
by: Areti Kalfoutzou, et al.
Published: (2024-12-01)

Health care utilisation preceding relapse or second malignant neoplasm after childhood acute lymphoblastic leukaemia: a population-based matched cohort study
by: Alina Zalounina Falborg, et al.
Published: (2021-08-01)

A case report on a patient with acute lymphoblastic leukaemia, with unusual side effects, using the intravenous route for administration of cytarabine versus the subcutaneous route
by: Aadarshita Verma, et al.
Published: (2024-01-01)

Treatment of newly diagnosed paediatric acute Lymphoblastic leukaemia on BFM- based chemotherapy protocol & feasibility and outcome from a tertiary care center in India
by: Vipin Khandelwal, et al.
Published: (2024-01-01)

Real-world experience of genetic profile, treatment outcomes and complications of paediatric BCP-Acute Lymphoblastic Leukaemia from a tertiary care government institute in India
by: Poorvi Kapoor, et al.
Published: (2024-01-01)

Digital India for pediatric acute lymphoblastic leukemia (ALL): Tracking reports during maintenance phase using a web-based application
by: Subham Kumar, et al.
Published: (2024-01-01)

A Novel Method for Preparation of Carrageenan/Fish Scale Collagen/Allopurinol Biocomposite Film
by: Quoc Manh Vu, et al.
Published: (2021-01-01)

A Brief Review of Analytical Methods for the Estimation of Allopurinol in Pharmaceutical Formulation and Biological Matrices
by: Hemraj Sharma, et al.
Published: (2021-01-01)

Acute Lymphoblastic Leukemia following Lenalidomide Maintenance for Multiple Myeloma: Two Cases with Unexpected Presentation and Good Prognostic Features
by: Abdullah M. Khan, et al.
Published: (2018-01-01)

Relapsed childhood T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma
by: Andrew D. Hughes, et al.
Published: (2025-01-01)

AN AUDIT OF ACUTE LEUKAEMIA IN A NIGERIAN TERTIARY INSTITUTION
by: John Ayodele Olaniyi, et al.
Published: (2014-08-01)

ANORECTAL PATHOLOGIES IN THE COURSE OF ACUTE LEUKAEMIAS: PREDICTIVE PARAMETERS
by: Fatma Yılmaz, et al.
Published: (2024-08-01)

Comparison of Febuxostat and Allopurinol in the Treatment of Patients with Chronic Kidney Disease Stage 3∼5 with Hyperuricemia
by: Zhimin Liao, et al.
Published: (2022-01-01)

Design and Optimization of Colorimetric Paper-Based Analytical Device for Rapid Detection of Allopurinol in Herbal Medicine
by: Rimadani Pratiwi, et al.
Published: (2019-01-01)

Total body irradiation-based myeloablative conditioning for acute lymphoblastic leukaemia patients undergoing allogeneic haematopoietic stem cell transplantation: the best way to prevent relapse in a real-world scenario
by: Mario Delia, et al.
Published: (2025-01-01)